Tamar Raz, PhD – CEO
Prior to joining Hadasit, Tamar served as VP Marketing and Strategy at Ramot, the Technology Transfer Company of Tel Aviv University, and was responsible for the company strategic alliances, marketing activities and commercialization. Tamar managed the establishment and served as CEO of Allergene, an Israeli start-up company that was founded as an incubator project.
Tamar’s PhD and MSc were earned in Cell Biology from Tel Aviv University School of Medicine. Expertise include; commercialization of medical technologies from the academic/ laboratory bench to the industry in order to turn ideas into viable products and services; establishment and management of corporate and academic relationships, pre-clinical development operations; raising funds including investment of venture capital, corporate collaborations, contractual research relationships and government grants.
Gil Granot-Mayer – CEO
Gil Granot-Mayer is the CEO of Yeda Research and Development Co. which is the commercial arm of the Weizmann Institute of Science. He took the position of CEO in 2016 after having served as Yeda’s Deputy CEO & General Counsel for 10 years.
Gil serves as Co-Chairman of ITTN (the Israeli Tech Transfer Organization) and on the board of directors of several of Yeda’s spun-off companies.
Prior to joining Yeda, Gil practiced law as a litigator and commercial attorney in several of the top prestigious law firms in Israel’s private sector.
Gil holds an MBA degree from the Leon Recanati Graduate School of Business and Administration as well as a LL.B. degree (cum laude) (Tel-Aviv University).
Gil has been a member of the Israel Bar Association since 1997, and is a frequent speaker in various forums covering issues related to Intellectual Property, Licensing, Innovation and Technology Transfer from the academia.
Venue & Opening Hours
David Intercontinental Hotel, Tel-Aviv.
Monday, Oct. 22nd 2018, 09:00 – 17:00